Clinical trial
IM-862 in Treating Patients With Recurrent Ovarian Cancer
NCT00003773 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00003773 |
|---|---|
| Title | IM-862 in Treating Patients With Recurrent Ovarian Cancer |
| Official title | Phase I Study of Escalating Doses of IM-862 in Patients With Ovarian Cancer |
| Lead sponsor | University of Southern California, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | oglufanide disodium |
| Enrollment | 43 |
| Start date | Feb 1, 1999 |
| Primary completion | Jul 1, 2000 |
| Completion | Aug 1, 2001 |
| First posted | Jun 3, 2004 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: